- Home
- EVTV vs ALZN Comparison
EVTV vs ALZN Comparison
Compare EVTV & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EVTV | ALZN |
|---|---|---|
| Founded | 2012 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0M | 8.2M |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | EVTV | ALZN |
|---|---|---|
| Price | $0.44 | $2.05 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $28.00 |
| AVG Volume (30 Days) | ★ 2.1M | 46.3K |
| Earning Date | 11-20-2025 | 12-09-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,696,856.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 113.69 | N/A |
| 52 Week Low | $0.40 | $1.88 |
| 52 Week High | $14.00 | $11.70 |
Technical Indicators
Market Signals| Indicator | EVTV | ALZN |
|---|---|---|
| Relative Strength Index (RSI) | 25.38 | 39.87 |
| Support Level | $0.40 | $2.10 |
| Resistance Level | $0.52 | $2.27 |
| Average True Range (ATR) | 0.14 | 0.11 |
| MACD | -0.06 | -0.00 |
| Stochastic Oscillator | 7.69 | 7.14 |
Price Performance
Historical ComparisonAbout EVTV Envirotech Vehicles Inc.
Envirotech Vehicles Inc is a provider of purpose-built zero-emission electric vehicles focused on reducing the total cost of vehicle ownership and helping fleet operators unlock the benefits of green technology. It recognizes revenue from the sales of zero-emission electric vehicles and vehicle maintenance and inspection services. The Company serves commercial and last-mile fleets, school districts, public and private transportation service companies and colleges and universities to meet the increasing demand for light to heavy-duty electric vehicles.
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.